Shopping Cart 0
Cart Subtotal
USD 0

Novozymes AS (NZYM B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Novozymes AS (Novozymes) is a biotech company that produces, markets and sells a range of industrial enzymes and microorganisms. The company provides enzymes for detergents, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning and wastewater treatment and bioinnovation solutions to minimize the CO2 emissions. Novozymes's products also find applications in hand and automatic dishwashing soaps, laundry detergents and professional cleaning products among others. The company has operational presence in the countries of the Europe, Middle East and Africa, North America, Asia Pacific and Latin America regions. Novozymes is headquartered in Bagsvaerd, Denmark.

Novozymes AS (NZYM B)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Novozymes AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Novozymes AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Novozymes AS, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Paras Biopharma Enters into Agreement with Novozymes 10

Novozymes Biopharma Enters Into Agreement With Thiologics To Offer Drug-Albumin Conjugation Platform 11

Novozymes Biopharma Enters Into Research Agreement With EpiVax To Advance Treatment For Autoimmune Diseases 12

Licensing Agreements 13

yooyoung pharma Enters into Licensing Agreement with Novozymes 13

Epivax Enters into Licensing Agreement with Novozymes Biopharma 14

Sanofi Pasteur Enters Into Licensing Agreement With ORGANOBALANCE For Saccharomyces Cerevisiae 15

Equity Offering 16

Albumedix Spin Off from Novozymes 16

Defensin Therapeutics Spin Out from Novozymes 17

Acquisition 18

Novozymes Acquires Organobalance 18

Novozymes AS-Key Competitors 19

Novozymes AS-Key Employees 20

Novozymes AS-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Affiliate 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

Novozymes AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Novozymes AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Novozymes AS, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Novozymes AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Novozymes AS, Deals By Therapy Area, 2012 to YTD 2018 8

Novozymes AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Paras Biopharma Enters into Agreement with Novozymes 10

Novozymes Biopharma Enters Into Agreement With Thiologics To Offer Drug-Albumin Conjugation Platform 11

Novozymes Biopharma Enters Into Research Agreement With EpiVax To Advance Treatment For Autoimmune Diseases 12

yooyoung pharma Enters into Licensing Agreement with Novozymes 13

Epivax Enters into Licensing Agreement with Novozymes Biopharma 14

Sanofi Pasteur Enters Into Licensing Agreement With ORGANOBALANCE For Saccharomyces Cerevisiae 15

Albumedix Spin Off from Novozymes 16

Defensin Therapeutics Spin Out from Novozymes 17

Novozymes Acquires Organobalance 18

Novozymes AS, Key Competitors 19

Novozymes AS, Key Employees 20

Novozymes AS, Subsidiaries 21

Novozymes AS, Affiliate 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Novozymes AS, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Novozymes AS (Novozymes) is a biotech company that produces, markets and sells a range of industrial enzymes and microorganisms. The company provides enzymes for detergents, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning and wastewater treatment and bioinnovation solutions to minimize the CO2 emissions. Novozymes's products also find applications in hand and automatic dishwashing soaps, laundry detergents and professional cleaning products among others. The company has operational presence in the countries of the Europe, Middle East and Africa, North America, Asia Pacific and Latin America regions. Novozymes is headquartered in Bagsvaerd, Denmark.

Novozymes AS (NZYM B)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Novozymes AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Novozymes AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Novozymes AS, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Paras Biopharma Enters into Agreement with Novozymes 10

Novozymes Biopharma Enters Into Agreement With Thiologics To Offer Drug-Albumin Conjugation Platform 11

Novozymes Biopharma Enters Into Research Agreement With EpiVax To Advance Treatment For Autoimmune Diseases 12

Licensing Agreements 13

yooyoung pharma Enters into Licensing Agreement with Novozymes 13

Epivax Enters into Licensing Agreement with Novozymes Biopharma 14

Sanofi Pasteur Enters Into Licensing Agreement With ORGANOBALANCE For Saccharomyces Cerevisiae 15

Equity Offering 16

Albumedix Spin Off from Novozymes 16

Defensin Therapeutics Spin Out from Novozymes 17

Acquisition 18

Novozymes Acquires Organobalance 18

Novozymes AS-Key Competitors 19

Novozymes AS-Key Employees 20

Novozymes AS-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Affiliate 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

Novozymes AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Novozymes AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Novozymes AS, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Novozymes AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Novozymes AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Novozymes AS, Deals By Therapy Area, 2012 to YTD 2018 8

Novozymes AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Paras Biopharma Enters into Agreement with Novozymes 10

Novozymes Biopharma Enters Into Agreement With Thiologics To Offer Drug-Albumin Conjugation Platform 11

Novozymes Biopharma Enters Into Research Agreement With EpiVax To Advance Treatment For Autoimmune Diseases 12

yooyoung pharma Enters into Licensing Agreement with Novozymes 13

Epivax Enters into Licensing Agreement with Novozymes Biopharma 14

Sanofi Pasteur Enters Into Licensing Agreement With ORGANOBALANCE For Saccharomyces Cerevisiae 15

Albumedix Spin Off from Novozymes 16

Defensin Therapeutics Spin Out from Novozymes 17

Novozymes Acquires Organobalance 18

Novozymes AS, Key Competitors 19

Novozymes AS, Key Employees 20

Novozymes AS, Subsidiaries 21

Novozymes AS, Affiliate 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Novozymes AS, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.